Sign in to continue:

Wednesday, March 4th, 2026

AIA Group (1299 HK) 2026 Outlook: Strong Growth, Top Sector Pick & 27% Upside Potential

Broker Name: China Galaxy International Securities (Hong Kong) Co., Limited
Date of Report: February 9, 2026

Excerpt from China Galaxy International Securities (Hong Kong) Co., Limited report.

Report Summary

  • AIA Group’s recent 8% share price drop is seen as excessive and mainly triggered by a minor reduction in Capital Group’s stake, which quickly reversed as Capital Group raised its stake above 5% again. The report reassures that this is not a repeat of 2024’s sharp underperformance, as Capital Group is not exiting AIA.
  • Strong growth is expected for AIA due to robust FY25 forecasts, opportunities in capturing rising foreign currency deposits and maturing time deposits in mainland China, and a rebound in Hong Kong insurance agent growth. AIA remains the broker’s top sector pick with a reiterated Add rating and target price of HK\$106, offering a 27% upside.
  • Key upside catalysts include strong FY25 results, clearer financial targets, and China expansion, while risks include capital controls, regulatory changes, and investment yield pressures. AIA trades at a premium valuation versus peers, justified by its lower risk profile and consistent shareholder returns.
  • Financial highlights project double-digit EPS growth from FY25 to FY27, rising ROE, and improving dividend yields. The report underscores AIA’s strong embedded value growth, sector leadership, and resilient business model.

above is an excerpt from a report by China Galaxy International Securities (Hong Kong) Co., Limited. Clients of China Galaxy International Securities (Hong Kong) Co., Limited can be the first to access the full report from the China Galaxy International Securities (Hong Kong) Co., Limited website : chinastock.com.hk

Anteris Technologies IPO: A Game-Changer in Heart Valves, Oversubscribed by 9x

1. IPO Details Purpose of IPO: Anteris Technologies plans to use IPO proceeds to advance R&D for its flagship DurAVR transcatheter heart valve, expand production facilities, and boost global commercialization. Approximately $100 million of...

Singapore Banks: The Star Performers You Shouldn’t Ignore in 2024

Singapore Banks: The Star Performers You Shouldn’t Ignore in 2024 Why Banks Are Winning Big Singapore’s big three banks—DBS, OCBC, and UOB—have been riding high amid the Straits Times Index’s strong performance in 2024....

Singapore Stock Market Hits New Highs in July 2025: Key Drivers, Sector Performance, and Outlook

Broker: CGS International Date of Report: July 31, 2025 Singapore Stocks Surge to New Highs: Market Outlook, Key Movers, and Sector Trends for July 2025 Singapore Market Overview: Riding High Amid Global Uncertainty Singapore’s...

   Ad